AIM-HI draws startups from the deep pipeline of NFCR funded scientists and the best-in-class global scientist-entrepreneur community.
Every year, hundreds of innovations and discoveries take place in research labs, academia, and leading cancer centers around the world. Surprisingly, only a small percentage ever make it into commercial ventures. The traditional commercialization approach facilitated by university Technology Transfer Offices (TTOs) have met meager outcomes.
AIM-HI sources deals from a deep pipeline. We leverage our relationships with NFCR and Asian Foundation for Cancer Research (AFCR), to curate the best entrepreneurial projects from their hosted pitch competitions. Namely, the Salisbury Award for Entrepreneurial Translational Research and the Bridging Research from Academia to Cancer Entrepreneurship (BRACE) Award. AIM-HI invites the finalists from these competitions to compete in our own Venture Competitions.
AIM-HI’s venture accelerator approach helps the scientist-entrepreneur focus on the technology while partnering with them to provide the necessary business, financial, legal and infrastructure support from the entrepreneurial ecosystem.
AIM-HI has invested in the following outstanding startups, made up of scientist-entrepreneurs and their brilliant ideas with commercial potential. Please click on each company to read more of their story.